AWS HPC Blog

Tag: Drug Discovery

Predict the unpredictable: Disrupting drug lead optimization using quantum mechanics simulation in the cloud

Quantum mechanics meets drug discovery: QSimulate’s latest advancements in QM-based FEP simulation are poised to transform the industry. Our blog post takes you on a journey through the groundbreaking science and innovative software that are redefining the future of drug design.

How Caris Life Sciences processed 400,000 RNAseq samples in 2.5 days with AWS Batch

How Caris Life Sciences processed 400,000 RNAseq samples in 2.5 days with AWS Batch

In the race to deliver precision medicine, time is of the essence. Caris Life Sciences, a pioneer in this field, leveraged AWS Batch to build a highly scalable solution that processed hundreds of thousands of genomic samples in record time. Discover how they achieved this remarkable feat and the key services that powered their breakthrough.

Best practices for running molecular dynamics simulations on AWS Graviton3E

Best practices for running molecular dynamics simulations on AWS Graviton3E

If you run molecular dynamics simulations, you need to read this. We walk through running benchmarks of popular apps like GROMACS and LAMMPS on new Hpc7g instances and Graviton3E processors. The results – up to 35% better vector performance versus Graviton3! Learn how to optimize your own workflows.

Accelerate Drug Discovery with NVIDIA BioNeMo Framework on Amazon EKS

Accelerate drug discovery with NVIDIA BioNeMo Framework on Amazon EKS

This post was contributed by Doruk Ozturk and Ankur Srivastava at AWS, and Neel Patel at NVIDIA. Introduction Drug discovery is a long and expensive process. Pharmaceutical companies must sift through thousands of compound possibilities to find potential new drugs to treat diseases. This process takes multiple years and costs billions of dollars, with the […]